|
CCT3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.75030031871415E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.82589523898014E-11 |
| Normal-vs-Stage2 |
3.585800E-04 |
| Normal-vs-Stage3 |
2.30919999999468E-06 |
| Normal-vs-Stage4 |
3.160100E-02 |
| Stage1-vs-Stage2 |
5.599600E-01 |
| Stage1-vs-Stage3 |
5.437600E-01 |
| Stage1-vs-Stage4 |
1.555880E-03 |
| Stage2-vs-Stage3 |
9.538800E-01 |
| Stage2-vs-Stage4 |
9.582100E-02 |
| Stage3-vs-Stage4 |
4.574400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.80300013702595E-10 |
| Normal-vs-AfricanAmerican |
1.979370E-03 |
| Normal-vs-Asian |
5.268800E-01 |
| Caucasian-vs-AfricanAmerican |
5.975400E-01 |
| Caucasian-vs-Asian |
3.466000E-01 |
| AfricanAmerican-vs-Asian |
5.372600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.72000216689139E-11 |
| Normal-vs-Female |
3.81590000000376E-05 |
| Male-vs-Female |
2.168300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.439900E-02 |
| Normal-vs-Age(41-60Yrs) |
4.0988001881459E-10 |
| Normal-vs-Age(61-80Yrs) |
1.36219999946618E-07 |
| Normal-vs-Age(81-100Yrs) |
5.251700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.329800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.156400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.845000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.583770E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.977600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.117200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.764990E-03 |
| Normal-vs-Grade 2 |
1.55049972860866E-10 |
| Normal-vs-Grade 3 |
2.49079999958823E-07 |
| Normal-vs-Grade 4 |
5.655100E-03 |
| Grade 1-vs-Grade 2 |
8.826200E-01 |
| Grade 1-vs-Grade 3 |
7.770600E-01 |
| Grade 1-vs-Grade 4 |
4.618800E-01 |
| Grade 2-vs-Grade 3 |
3.509600E-01 |
| Grade 2-vs-Grade 4 |
6.379600E-02 |
| Grade 3-vs-Grade 4 |
2.662200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.05360000002275E-06 |
| Normal-vs-ccB subtype |
9.78739977952614E-10 |
| ccA subtype-vs-ccB subtype |
1.573570E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.6116000169435E-09 |
| Normal-vs-N1 |
5.228800E-01 |
| N0-vs-N1 |
6.135600E-02 |
|
|
